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We have reported previously that human keratino-
cytes synthesize and secrete acetylcholine and that 
muscarinic cholinergic drugs have effects on kerati-
nocyte proliferation, adhesion, and nligration. This 
study defines the location of muscarinic acetylcho-
line receptors in hUinan epidermis and describes 
some pharmacologic and molecular properties of 
these receptors. Confocal microscopy el11ploying the 
anti-muscarinic receptor monoclonal antibody M35 
visualized the receptors in the intercellular areas of 
normal human epidernlis. Using immunoelectron 
microscopy, the receptors appeared to be attached to 
the keratinocyte plasl11a l11el11branes. Functional, 
high-density (Bmax = 8.3 nmol/2 X 106 cells) and 
high-affinity (Kd = 21.5 nM) l11uscarinic receptors 
were demonstrated by saturable binding of the re-
versible radioligand [3H)quinuclidinyl benzilate to 
the surfaces of freshly isolated epiderl11al cells at O°C. 
Receptor proteins were separated by gel electro-
c have demonstrated previously that human 
epidermal keratinocytes synthesize, sto re, 
release, and degrade ace tylcholinc [1] . T he 
effects produced by this autocrine and para-
crine secretion of acetylcholine are mediated 
by both fa milies of cholinergic recepto rs present in human kerati-
nocytes, i. e ., ionotropic nicotinic receptors and mctabotropic mus-
carinic receptors . In particular, human keratinocytes express the 
neuronal (ganglionic) a3 {321 {34 nicotinic acetylcholine receptor. "I 
Human keratin ocytes also have functiona l muscarinic acetylcholine 
receptors (mAChRs), as we have demonstrated in experiments 
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phoresis. An apparent isoelectric point of pH 4.3 was 
deterl11ined in il11l11unoblots of sodium-cholate-solu-
bilized receptors separated on isoelectric-focusing 
gels. Three protein bands, two at approximately 60 
kDa and one at 95 kDa, were visualized in il11l11uno-
blots of l11elnbrane-bound or solubilized receptors 
separated by sodium dodecylsulfate-polyacrylal11ide 
gel electrophoresis. The covalent, irreversible ligand 
[3H)propylbenzilylcholine mustard confirl11ed these 
results . Thus, human keratinocytes express a hetero-
geneous population of muscarinic cholinergic recep-
tors. Because human keratinocytes also express nic-
otinic cholinergic rect'-ptors, endogenously secreted 
acetylcholine may control different biologic pro-
cesses in these cells by activating different types of 
their cholinergic receptors. Key lI1ords: cOllfocal ",icros-
copyli",,,,,,"oelectl'OlI IIIicroscopylradioiigalld bittdillglimltw-
lIoblottillglmollociollai alltibod), M3 5. ] Illvest DeJ'IIIatol 
104:95-100, 1995 
using muscarinic cholinergic drugs [2,3 ]. In these previous studies, 
muscarin.ic agonists increased keratinocyte adhesion and migration, 
whereas mllscarinic antagonists caused ceU-cell detachment (acan-
tholysis) and decreased migration . In the present study, we sought 
to localize keratin ocyte mAChRs in norm al human epide011is, 
determine their ligand- binding abilities, and define some of their 
biochemical charactcl;stics. 
Using an ti-mAChl:t monoclonal antibody (MoAb) M35 [4] , we 
visua.lized keratinocyte mAChRs by indirect imm1l110fiuorescence, 
immunoelectron microscopy, and immunoblotting. T he reversible 
muscarinic radioligand eH]quinuclidil1yl benzilate ([3H]QNB) [5] 
identified pharmacologically active mAChRs on cell surfaces of 
keratinocytes that we isolated fres hly £i'om n0011a1 human epider-
mis. T he covalent, irrevcrsible muscarinic radio ligand eH]propyl-
benzilylcholine mustard ([3H]PrBCM) [6] identified mAChRs 
among the sodium dodecylsulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE)-resolved keratinocyte-membranc proteins. 
T he resu lts suggest that keratinocyte-ceU surfaces contain a heter-
ogeneous population of mAChRs and that these may be structurally 
di1ferent from muscarinic receptors expressed by other cell types . 
MATERIALS A N D METHODS 
Indirect Illll1111110fillorcsccllcC Normal human skin obtained from 
cosmetic surgical procedures on the f.,ce and neck was used as a substrate for 
indirect inllTIUnoA uorcsccl1 cc and inl111unoclectron Inicroscopy. hnaging 
used a laser scanning confocal microscope, described below. For indirect 
immunoAuorescence. skin specimens were fixed immediately in icc-cold 
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Zamboni' s fixative [7], held at 4°C overnight, transferred to phosphate-
buffered sa Une (PBS) supplemented w ith 20% sucrose, and refrigera ted for 
24 h or until sectioned. Thick (up to 100 /-Lm) sections were cut using a 
freez ing, sliding microtome (American Optical Co., Buffalo, NY) , placed in 
spot plates, and flooded with staining buffer (0 .1 M PBS with 20'% sucrose, 
contain ing 0.3% T ri ton X-100 [Sigma, St. Louis, M O ] and l 'Yo normal goat 
serum). Floating sections were incubated for 16 h at 4°C on a rotating table 
with mouse anti-mAChR MoAb M35 (11400 ; C hemunex, Maisons-Alfort, 
France) and rabbi t polyclonal antiserum to the neuro peptide protein gene 
product (PGP) 9 .5 (1/100; Ultraclone, WeLlow, UK), which immunostains 
ep idermal nerve fibe rs [8]. All dilutions , incubations, and washes were done 
in sta ining buffer. Nonimmune mouse and rabbit sera were used as negative 
controls. Binding of MoAb M35 was visualized by cyanine-3. 18-labe led 
goat anti-mouse IgM secondary antibody-fluorophore, and binding o f 
antibodies to PGP 9.5 was visualized by cyanine-5.1 8-labeled goat anti-
rabbit IgG secondary an ti body Uackson Immunoresearch, W est Grove, 
PAl, both diluted 1 :200 in PBS. Washed sec tions were mounted on 
gelatin-coated coverslips, dehydrated through alcohols, and cleared with 
methyl sa li cylate (Fisher Scientific, Pittsburgh, PA) . Some doub le- and 
trip le-staining experiments also used antibodies to human collagen type IV 
(Chemicon, Temecula, CAl and the cellu lar antigens S100 (Oako Corp ., 
Carpinteria, CAl and COla (Biodesign International, Kennebunk, ME) . 
Specimens were examined initially with a Nikon epifiuorescence micro-
scope to se lect areas for further examination in the laser scanning confoca l 
microscope. T he sections then were imaged using an MRC-600 Laser 
Scanning Confocal Microscope Imaging System, equipped with a krypton/ 
argon ion laser (Bio-Rad Life Science, Hercules, CAl and a fiJter set 
appropriate fo r the specific visuali zation of cyanine 3.18 and 5.18 [9] . 
Multiple optica l sections acquired at 2- 4-/-Lm intervals throughout the depth 
of the specimen were stacked and projected into a single in-focus image 
using the software sup plied w ith the confocal microscope . 
Irnrnunoelectron Microscopy The skin samples, fi xed in periodate-
Iysine-paraformaldebyde [10] and embedded in K4M Lowicryl (Chemische 
Werke Lowi GmbH, Waldkraiburg, Germany) [11] , were sectioned to a 
thickness of 70-90 nm with an LKB Ultramicrotome, and picked up on 
formvar-coated nickel grids. Post-embedding immunogold staining was 
performed following a protocol deta iled elsewhere [1 2] . The grids were 
examined with the EMU4 electron microscope (R.CA, Camden, NJ) . 
Radioligand Binding To assess total binding, kc rati nocytes were iso-
lated from neonatal foreskin epidermal sheets after overnight trypsinization 
[1] , countcd with a hemocytometer, loaded in 1.5-ml microcentrifuge tubes 
at a density of 2 X 10" cells/tube, put on icc, and exposed in triplica te to 
0.01 to 100-nM concentrations of [3H ]QNB (43 C i/ mmol; Ou Pont NEN 
R.esearch Products, Boston, MA; NEN) for 60 min [2]. N o nspecific binding 
was measu red in para llel tubes, in which kcratinocytes were cxpo cd to 
[3H ]QNB in the presence of 1 OO-fold concentrations of atropine. The ce ll s 
then were washed with ice-cold PBS and solubi lized by 1 % SOS, and the 
radioactivity was coun ted in the LKB liquid scin ti llation counter. T he 
specific b inding was computed by subtracting the nonspecific binding from 
tota l bi.nding, and the binding capacity (BII/ax) and dissociation constant 
(Kd) were calculated by the computer software ENZFITTER (Biosoft, 
Ferguson. MO) wi.th simple weighting. 
Gel E lectrophoresis Conflucnt mono layers fo rmed by second-passage 
normal human foreskin keratinocytes ll] were washed with PBS and 
overlaid with buffer A, consisting of 50 mM sodium phosphate buffer (PH 
7.4) supplemented to contain the following protease inhibitors: 0.5 mM 
phenylmethylsulfonyl flu oride , 1. mM iodoacetamide, 1 mM benzamidinc, 
0 .1 mg/ ml bacitracin, 4 /Lg/ml leupeptin. 5 p.g/ml soybean trypsin inhibi-
tor, I /-Lg/ml pepstatin A, 1. mM ethylenediamin etetraacetic acid (EOTA), 
0 .5 mM phenathro line, and 1 /-Lg/ml ap rotinin (all fro m Sigma). T he cell s 
then were removed fro m the flask bottom using a rubber poUceman, 
res uspended in buffer A, put on icc , and di srupted by freezing-thawing. Cell 
nuclei were removed by centrifugation at 1000 X c~ for 10 min at 4°C. 
Plasma membranes were separa ted from the resultant supernatants by 
centrifugation at 40,000 X g for 60 min at 4°C. To covalentl y radiolabel the 
mAC hRs, 1 mg ofkeratinocyte-mcmbrane prote ins was preincubated with 
30 nM [3H]PrBC M (55 .5 Ci/ mmol; NEN) for 30 min at 37°C. T he 
specificity of [3H]PrBCM binding to keratinocyte mAC hKs was con trol.1ed 
by labeling half of the membrane pro teins in the presence of a 100-fold 
concen tration of nonradioactive PrBC M (NEN) . 
To so lubilize [3H ]PrBCM-Iabcled mAChRs fro m keratillocyte plasma 
membranes, the samples were treated with buffer A supplemented to 
contain 1% (w/v) digitonin and 0.1% (w/v) sodium cholate for 30 min , 
followed by 30 min centrifugation at 100,000 X g at 4°C. Solubilized 
mAChR proteins were concentrated by lyop hiU za tion and reso lved by 
SOS-PAG E on the PhastSystem appa ratus (Pharmacia LKB Biotechnology 
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AB, Uppsala, Sweden) using the protocol and softwarc providcd by the 
manufacturer. After a 20-min run at 15°C, the ge ls were fixed, d ried , and 
sliced with a razo r b lade. Each of the obtained 1- mm strips was placed into 
separate scintillation v ials and incubated overnight in 1 ml SOLVABLE 
(NEN) to extract radioactivity. After this, each via l received 5 ml of the 
ATOMLIGHT scintil.1ation cockta il (NEN) , which is compatible with the 
solvent, and the radioactivi ty was measured in the LKB scinti ll ation counter. 
Some SOS-PAGE experiments used nonsolubili zed , mcmbrane-bound ke-
ratinocyte mAC hRs labeled with [,H]PrBC M. The loca tion of solubilized , 
or membrane-bound, keratinocyte mACh.R.s in the SOS-PA GE gels was 
verified by immunoblottin g, using the procedure similar to tha t described 
below for isoelectri c focusing of receptor prote ins. 
T hc isoelectric focusing expcriments used nonlabcled , nondena tured 
mAC hRs solub il ized from keratin ocyte plasma membranes. T he so lubili zed 
receptors together with the isoelectric po in t (PI) markers (IEF MIX 3.6-9 .3 
kit; Sigma) were loaded near the cathodal end of the IEF 3-9 gels 
(Pharmacia LKB Biotechnology AB) install ed onto the PhastSystem ap pa-
ratus, and the gels were run using the software provided by the manuf.1c-
turer. Halfofthe gels were sta ined by amido black dye to v isuali ze separated 
pro te ins. The other half of the gels were uscd to locatc receptor prote ins by 
immuno blotting [1 3]. T he proteins were transferred to the lmmobilon-P 
transfer membranes (Mi lUpore Corp ., Bedford, MA) , blocked overnight in 
50 mM Tris-buffered saline , pH 7.4, containing 1. u!c, bovine serum albumin, 
0.05'!!', Tween-20, and 1% polyvinylpyrro lidone- 40 (Sigma), and then 
treated for 45 min at 25°C with MoAb M35 diluted 1:500 in the b locking 
so lution. Bind.ing of MoAb M35 was visualized using biotinylated antibody 
against mouse immunoglo bulins, streptavidin alkaline phosphatase , and 
N ew Fuchsin C hromogen , all included in a OAKO LSAB 2, AI' kit (Oako 
Corp .). In contro l experiments, MoAb M35 was e ithe r omitted or replaced 
by the isotype control mOuse IgM (Sigma). 
RESULTS 
Localization of Keratinocyte mAChRs T he anti-mAC hl"l... 
MoAb M35 specifically stained normal human kerati.nocytes, as 
shown by both indi.rect immunoflu orescence and inlmunoelectron 
microscopy. Using a lascr scann ing confoca l microscope, images 
acquired at 2-4-p,m inte rvals were m erged into a single two-
dimcnsional image. As seen in Fig 1, MoAb M35 stained ill terce l-
Figure 1. Laser scanning confocal luicrogra ph of inlluunofluorcs-
cently stained mAChR in normal human epidermis. T lu s section of 
normal hum an facia l skin was sta ined simultaneously with antibod ies against 
mA ChR (MoAb M35) and aga inst PGP 9.5. MoAb M35 was v isualized by 
cyanine-3 .18-labeled goat anti-mouse IgM (red) , and antibodies to PGP 9 .5 
were visual ized by cyaninc-5. 18 - labeled goat anti-rabbit IgG (green) . This 
image is a proj ection offive optica l sections collected at l-/-Lm interva ls w ith 
a 40 X N ikon Fluo r objective. The epidermal-dermal junction was visua l-
ized by anti-co ll agen type IV antibody and shown as a dashed line. N ote: in 
epidermis, MoAb M35 stai ns keratinocytes but no t PGP-9.5- positive epi-
dermal nerves. T he MoAb-M 35-positivc cell s in the upper dcrmis are 
appa rently fibrob lasts, wh ich also ex]} rcss lu gh-density mA C hRs (see 
D;sCl/ss;oll) . Bar, 100 /-Lm . 
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lular areas of epidermis (red), T he staining was densest at the basal 
cell level but extended upward to the spinous and granular cell 
layer, leaving dead corneocytes unstain ed . MoAb M35 did not stain 
epiderma l n erves, as verified by visualiz ing nerve fib ers in the same 
microscopic fi e ld w ith antibody to PGP 9.5 (Fig 1, green) . MoAb 
M35 also did not stain epidermal structures positive for collagen 
type IV or cellular antigens S100 and CDla (data not shown) . 
At the electron microscopic level, mAChRs w ere found on the 
kera tin ocyte-cell surfaces. T he morphology of the keratinocyte-cell 
membrane was well preserved at th e site of cell-cell contact (Fig 2). 
Other areas of the keratinocyte-cell m embranes were poorly pre-
served. Staining was de tected within the stratum basale and stratum 
spinosum overl ying desmosom es. No staining could be seen within 
hemidesmosomes. Control experiments, which either omitted 
MoAb M35 or replaced this primary antibody with m ouse nonlm-
mune ser'um, yie lded only minimal or no sta ining in both indirect 
immunofl uorescence and immunoelectron microscopy experi-
m ents. 
Ligand-Binding Properties of Keratinocyte mAChRs The 
whole-cell radioligand-binding assay showed saturable specific 
binding of the reversibl e muscarinic antagonist [3H]QNB to the cell 
surfaces of fi' eshly iso lated epidermal cells at O°C (Fig 3a) . Non-
specific binding never exceeded 5°;', of the total binding. To 
compute the BI/lax and Kd values, the binding data w ere analyzed 
Figure 2. Ultrastructural localization of keratinocyte mAChRs. 
Post-cmbedding immul1oclcctron microscopy of normal human f.1ciaJ skin 
sta ined with MoA b M35. Binding of the primary antibody was visnalized by 
is-11m gold particles (see Materials alld Meth()ds). Note: gold particles 
(amllvs) decorate ce ll surfaces of sp ino us keratil10cytes in the immediate 
vicinity of desmosomes (n ,I}) and on the plasma- membrane areas envelop ing 
desmosomal plaques (c). Bars: a, 250 nm; I), 130 11111 ; C, 265 11111 . 
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Figure 3. EquilibriuDl binding of ['HJQND to human keratino-
cytes. I-[uman epidermal kerati nocytes freshly isolated fro m neonatal 
foreskins were exposed to increasing concentration~ of eHJQNB in the 
absence (tota l binding) or presence (nonspecific binding) of a 100-fold 
concentration of atropine at O°C (sec' Materials alld Methods) . En'or bars 
represent SO of the data . Top: T he saturation curve showing specific 
binding (tota l binding - nonspecific binding) was obtail1ed in five inde-
pendent experiments , testing each concentration of the radioligand in 
triplicate. B Ot/() IIr: Bound versus free [' H)Q NB . II/scr demonstrates the 
Scatchard plot of the binding data. T he curve fitting and calcula tion of 
binding parameters Blllax and Kd were done by the computer sofrware 
EN ZFITTER using the da ta points fro m the saturation curve (1O/}) . 
using Scatchard plots (Fig 3b). T he tigand-binding capacity (Br ll nx) 
of the receptors was fowld to be 8.3 :t 1.2 nmol!2 X 106 cells, and 
the dissociation constant of tillS ligand (Kd) was 21.5 :t 6.6 nM . 
Each epiderma.l keratinocyte expressed approximately 2.4 X 105 
mAChRs, as detenl1ined by converting the obtained Brll ax value 
in to absolute numbers of receptors per cell . 
Molecular Weight and pI of Keratinocyte II1AChRs T he 
SDS-PAGE of either m embrane-bound or digi tonin /sodium-
cholate-solubilized kera tinocyte mAChRs covalently labeled by 
[3H]PrBCM brought similar results. T he major peak of radioactiv-
ity in the SDS-PAGE 8-25 gels migrated with proteins with a.n 
apparent m olecular mass (Mr) of 60 kDa (Fig 4) . T he amplitude of 
'this pea k was signjficantly diminished w hen keratinocyte-mem-
brane preparations were labeled [3H]PrBCM in th e presence of 
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Figure 4. Localization of [JH)PrBCM-lab cled keratinocyte 
mAChRs in SDS-PAGE gels . ResuJ ts of a represcntative experiment 
showing distribution of radioactiv ity in thc PhastGcl Grad ient 8-25 conta in-
ing keratinocyte-mcmbrane proteins. whk h were I;lbeled with CH]PrBCM 
in the absence (opell circlos) or presence (closed circles) of a 100-fold 
concentration of nonrad ioactive PrBCM , and then solub ilized with digito-
nin /sodium cholate. T he molecular weights in kDa are shown (a rm",s) on 
the top of the graph. T hese Mr markers were run parallel to lanes w ith test 
proteins 011 the same SDS-PAGE gels. 
nonradioactive PrBCM . A m inor rad ioactivity peak appea red at M,. 
of approximately 95 kDa (Fig 4). 
In Western b lots of both m embrane-boun d and solubilized 
receptors, the MoA b M35 consistentl y visualized a doubl e band 
with Mr of approximately 60 kDa and a sing le band at 95 kDa (Fig 
5). 
The pi of keratinocyte mAChR proteins was established by 
immunoblotting of d igitonin /sodiu m-cho late-solubilized recep tors 
resolved on the LEF 3-9 gels. The MoA b M35 visua lized a single 
protein band at pH of approximately 4.3 (Fig 5) . 
Replacing MoAb M35 w ith the isotype control m ouse Ig M or 
omitting the first- layer antibody abolished staining of Western blo ts 
of both SDS-PAGE- and isoelectdc-focusing-rcsolved receptor 
prote ins . 
DISCUSSION 
We believe the ski n uses cholinergic m o lecules to m ediate its 
fun ction. The cholin ergic neuromediator acetylcho line is secreted 
by human keratinocytes ill vi vo and in II i/yo [1] . Acetylcholjne 
m ediates ad hesion, motili ty, and prolifera ti on of keratinocytes by 
reacting with cholinergic recep tors on the ir cell su rfaces [2,3]. 
Acetylcholine and the m uscarinic agoni sts m ethacho line and be-
thanechol stimu late spreading of ke rati nocyte cytoplasm , cell-
substrate attachment, crawling locomotio n, and form ation of in te r-
cellular junctions. T hese agonists also p rotect the in tegrity of 
keratiJlocyte monolayers from the acantholytic effects of pem phigus 
antibody and reverse acantho lysis produced by pem phigus aJl ti-
body, the serine proteinase tryps in, and the calcium chelator 
EDTA. B lockade of keraOJlocyte acetylcho line receptors by mus-
carinic antagonists, such as atropine o r P rBCM, causes cell-cell 
detachment (acantholysis), abrogates migration, and sti mul ates 
proliferation . T hese previous stud ies showed that p utative 
mAC hRs mediate m etabotropic effects of endogeno us acetylcho-
line in human keratinocytes and prompted further stud ies o f the 
receptors, as reported herein. 
Both the indirect imm unofluorescence and inlmun oelectron 
microscopy tecluuques localized mAChRs in human epide rmi s. 
The receptors were vi sualized by specific MoAb M 35, raised 
against affinjty-purified calf brain mAChl"t [4]. T illS an tibody has 
been shown by others to localize mAChRs in various tissues and 
cells at both the light- and electron-microscopic levels [1 4, 15] . 
T H E J OU I~AL OF INVESTIGATIVE DERMATOLOGY 
MoAb M 35 recogni zes an extracellula r epito pe of mAChRs that is 
involved in signal tra nsdu ctio n from plasma m embranes [16] . 
Images of flu orescently stain ed mAChR sites w ere coll ected 
thro ug ho ut the tissue sectio n using a laser scanning confocal 
m icroscope and projected with confocal softw are into a single 
two-dimensio nal image. T his teclmique revea led mA C hRs o n 
ke ratin ocyte- cell borders. T he vertical orientation of the M35-
positiv.e cells in th e lower and middle epidermis and their ho rizon ta l 
o rientation in the upper epidermis agree wi th the respective 
ori en tatio ns of ke ratinocytes in these e piderm al areas [17] . M oAb 
M35 sta in ed the keratinocytes in the basa l cell layer m o re intensely 
than those in the middle and upper layers o f epidermis, impl ying a 
higher density of receptors o n basal cell s. MoAb M 35 also stained 
cell membranes in pure cul tures of norm al human keratin ocytes, 
w here the surface staining patte rn changed from hom ogeneous to 
in te rcellul ar as the cells di ffe rentiated in respo nse to increasing 
concen tratio ns of extracellular calcium.1" In the upper dermj s, 
MoAb M35 stallled fi bro blasts. T his w as expected because, using 
this an tibody, we (Grando SA, Bigliardi PL, Ze l.i ckson ED, unpub-
lished observations) and others [1 5] previo usly had v isualized 
mAChRs on celJ surfaces of cul tured human derm al and embryonic 
fi broblasts, respecti vely. 
Im m unoelectron nti croscopy sho w ed that M oAb M 35 stain s 
keratinocyte- cellmembranes associated with desm osom es. Because 
the pre-embedding techniq ue used in th is study did' not allo w us to 
p reserve cell m orpho logy, w e canno t rule o ut the presence o f 
m AChR on otber areas of the ke ra tinocyte-cell membranes . Prio r 
fixation of the tissue to preserve ce lJ m o rph ology in terfe red wi th 
biJld ing of M oA b M35. T herefore, the tissue w as processed w itho u t 
fixa ti on, disrup ting ke ratin ocyte-cell membran es in areas between 
th e ce ll -cell con tact poin ts. 
T he loca tio n of mAChRs o n keratin ocyte- cellmembranes would 
exp lain w hy M oAb M35 produces 3n intercellular staining pattern 
of epiderm is at the light-microscopic level. T he presence of mAChRs 
0 11 the membran e areas at the sites of kera tin ocyte ceLl-celJ con tacts 
would be useful if these receptors foster 111tercellular commllJllcations 
between epidermal cells, as we believe they do. 
t Grando SA, Big liard i PL, Zclickson BD, Da hl MY : Location and 
characte r of ke ratinocyte m ysca rinic recepto rs (abstr) . J fl lllcst Defl" atol 
1 01 :397, 1993. 
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F ig ure 5. Immunoblotting o f solubiliz ed k e r atinoc yte I11AChRs . 
Resul ts of a represen tati ve experiment showing protein bands recognized 
by MoA b M.35 among keratinocyte-mcll1brane proteins so lubilized with 
d igitonin /sodium cho late and resolved on thc SDS-PAGE PhastGel Gradi-
ent 8-25 ge ls (ltji 1<llIe) and on the IEF 3-9 ge ls (right lalle). T hese b:ll1ds did 
not appear in con tro] cxpcrinl cn ts, in which ilnl11l111oblottiJlg 111crnbrancs 
were treated w ith either the blocking bufFer or the isotype con tro l mo use 
IgM inste:ld of M oAb M35 . 
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Human epiderm al keratinocytes express approximately 2.4 X 105 
functional m AChRs per cell. T hi s is exactly the samc number of 
mAC hRs that we found previously on thc cell surfaccs of cultured 
human kcratinocytcs using ano ther muscarini c rad io ligand, CH]a-
tropin e, and another type of the whole-cc Ll binding assay [2] . 
Previously, the assay was performcd with cc Ll s grown to conAucnce 
and exposed to [3H]atropin e ill si(" in 96-wcll platcs . Other tissue 
cclls, such as fibrob lasts and acinar cells of exoerinc glands, also 
express high-density m AChRs, at approximately 2 X 105 [1 8] and 
2.5 X 10'1 [1 9] binding sitcs/cell, respectively, whcrcas Iympho-
cytcs have appl"Oximately 6 X 103 receptors/ceLl [20] . Pcrchellct c ( 
al [21] have shown similar rccepto rs in mouse keratinocytes. In 
these studics, ["HJacctylcholine spccificaLly bo und to thc cell 
surfaces of frcshly iso lated murine ep idcrmal ce LI s, and atropine 
aboljshed this binding. . 
T he Kd value for QNB binding to kcratinocyte m AChRs 
appeared to be 21.5 nM , and that fo r atropinc binding is 13 I'M [2]. 
This is in agrcem en t with the ligand- binding data summarizcd by 
Venter e( al [22] , showing that atropine binds to mAC hRs with 
mu ch hig hcr afrinity than QNB . T he Kd va lu es of 17.3 and 24 nM 
for QNB binding to mAChRs on in tact human lymphocytes 
[23,24] are similar to the 21.5-nM valu c th at we obtained using 
human ke ratinocytes. QNB binds to thc high-'lffini ty mAC hRs 
with Kd of approx im ately 10 - H M , and to the low-afrinity o ncs with 
Kd of appl"Oximatcly 10 - 5 M [25]. 
We believe that human ke ratinocytcs cxpress thrcc different 
mAC hR proteins, with apparcnt M,. of 60 kDa (two proteins) and 
95 kDa (onc protein) . T he two separatc peaks of radioactivity in 
CH]PrDCM-labelcd keratinocyte-m embra nc proteins resolved by 
SDS- PAGE su ggcstcd at leas t two separatc proteins w ith approxi-
matc Mrof60 and 95 kDa. Howcvcr, in W estern blots, MoAb M3 5 
resolved the 60-kDa rcccptors into two distin ct pl"Otcin bands. By 
comparison , [3H]PrDC M-labcled m AChR proteins from corneal 
epith elium yield at lcast two scparate pcaks in thc 45-60-kDa 
regio n and a siJlg le peak at 97 kDa [26]. T hc mAC hRs o n lacrim al, 
parotid, and pancrcatic acinar cclls hav c 1\11 ,. of 62 .8, 78, and 87.6 
kDa , respectivc ly [1 9]. Our ca lc ulated pi va lue for ke ratinocytc 
mAC hR protcins of pH 4.3 coincides with that reported for 
mAC hRs solubilized with digito nin from other ce Ll types [27 .28]. 
This corroborates thc notio n that mAChll.. typcs cxpressed by 
diJte rent cell types and in diffcren t species all have similar biochem-
ica l characte ristics [22] . 
T he fami ly of mA C hRs compriscs at leas t fiv e m o lccular sub-
types of sing le-s ubuni t transm embrane g lycopl"Oteins coupl ed to G 
protcins, i.e., putative gualunc nucleotide-binding rcgulatory pro-
teins [29] . Each mcmbe,' of this rcceptor superf.,mil y has sevcn 
m embran c-spanning a - hclica l domains, an cxtraccll u lar amino 
termina l c nd , and an intra ccllular carboxy terminal cnd . T he 
ligand-binding site is buried decply within the p lasma m cmbran c in 
thc thjrd transmembran c helix [6]. T hc thi rd cytoplasmic loop, 
bctween the fifth and sixth transm cmbranc hc lices, intc racts with G 
protein, and its amino acid scqucncc is uniqu c to cach type of the 
reccptor. W hcn an agonist binds to mAChR, thc rcceptor/G 
protein association increascs, and th is m odulates the activity of thc 
e ffector m o lecule. T he m1 , m 3, and m 5 m AChRs selcctively bind 
to a putative pertussis-tox in- inscnsiti vc G protein to stimul ate 
phospho lipase C. T hi s ca uses the rcleasc of inositol 1,4,5-triphos-
phate 3Jld d iaglyccro l, w hich in turn rclcase C a -I- '1- from in tra cel-
lul ar storcs and activatc protein kinases, respcctivcly. T hc m 2 aJld 
m 4 mAC hRs selectivcly couplc a putativc pertussis-toxin-sensi tive 
G protein to inlubit prcviously stimulatcd adcnylyl cyclase and also 
o pen potassium channels. T hc /11[,. of m1 , m 2, and m4 Il1AC hR 
subtypes is approximate ly 66 kDa , and that of m 3 and m 5 is 
approximatcly 92 kDa [30]. C urrcntly, wc are workjng to subtypc 
pharma co logicalJy and mo lccularly thc m AChR expresscd by 
human kcratinocytcs. T he presence of scveral mAChR typcs in 
human ke ratinocytcs would not surprise us becausc 1110 ,'e than onc 
typ e of mAChJl.. is cxprcssed by othcr no n- neuro nal cclls, such as 
blood-vessel endothc lium (1111, m 2, and m 3) [31] and nasal mu cosa 
(111 1 and m3) [32]. 
KERATIN OCYTE MUSCA I~I N IC RECEPTORS 99 
In conclusion, human kcratinocytcs both ill lIillo and ill lIitro 
exprcss high-density and high-affinity mA C hRs. T hese receptors 
are presen t in all layers of viable cpidermis but are seen primarily on 
thc cell surfaces of basal cells. T hc mAChR proteins solubilized 
from human keratinocytcs have differcnt molecular weights, sug-
gcstin g the presence of a heterogcneous receptor population. 
Acetylcholine, w hich is constantly produced and secreted by hu-
m an keratinocytes, may bind to and ac tivate thcse kera tinocyte 
muscarinic receptor subtypcs and keratinocyte nicotinic cholinergic 
rcceptors to contro l differcntia lly various biologic processes in these 
cclls in an au tocrine and paracrine way. 
Tllis stlldy ",as .<II/J}J()J1ed by researcll grallts jimll tile Denll arolog)' FOII",/a tioll alld 
M ill/ Il'sora Medical FOI II/dafioll til SA.C. 
We tll allk Ms. M icllelle 1I/il:0< alld Mr. Dalliel RII}Jplllall for tec/II/ical assis(allce 
l/l itl1 [(wIocnl ",icroscopy_ 
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